Salindawan, Abdul Razzaq D.
HRN: 21-72-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2023
AMPICILLIN 500MG (VIAL)
09/11/2023
09/17/2023
IV
250mg
Q6h
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes